Previous Close | 1.0100 |
Open | 0.7000 |
Bid | 0.3100 |
Ask | 0.5900 |
Strike | 350.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.7000 - 0.7500 |
Contract Range | N/A |
Volume | |
Open Interest | 2.22k |
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallFrance’s Macron Calls for Reset of Economic Ties With ChinaLamborghini Bros No More: Crypto Is Creating a New Wealth EffectThe shares
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats